Tokyo Tape
Sign in
← Torii Pharmaceutical

Annual report

4551.TEDINET S100QGWM
Period2022-01-01 → 2022-12-31
Filed2023-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
MetricValuePeriodScopeSource row
Revenue¥48.9bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥47.0bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥41.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥43.0bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥62.6bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥5.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥4.7bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥5.5bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥4.8bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income¥5.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.7bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.1bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥5.7bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥4.8bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥3.9bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥3.4bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income¥3.5bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥27.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥133.7bnat 2022-12-31StandaloneAssets
Total assets¥130.8bnat 2021-12-31StandaloneAssets
Total assets¥126.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥139.9bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥103.3bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥14.5bnat 2022-12-31StandaloneLiabilities
Total liabilities¥13.8bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥119.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥117.0bnat 2021-12-31StandaloneNet assets
Net assets / equity¥115.1bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥113.1bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥87.1bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥9.2bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.0bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥45.4bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥58.4bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥61.6bnat 2020-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥58.8bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥15.7bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥2.4bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥156m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥42.5bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥8.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥13.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥7.6bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥2.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥27.1bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥140.392022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥120.132021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥124.472020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥974.982019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥41.512018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥124.462020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482021-01-01 → 2021-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482019-01-01 → 2019-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482018-01-01 → 2018-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,243.08at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,165.38at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,097.55at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,029.3at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,103.28at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio89.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.5%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.8%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE3.3%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE2.9%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
ROE3.1%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE27.3%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
ROE1.3%2018-01-01 → 2018-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued28,800,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees563at 2022-12-31StandaloneNumber of employees
Employees560at 2021-12-31StandaloneNumber of employees
Employees568at 2020-12-31dStandaloneNumber of employees
Employees660at 2019-12-31dStandaloneNumber of employees
Employees1,049at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2022-12-31563 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 987
ItemContextValueUnit
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember117000000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember523000000JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember117000000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember117015000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember119224000000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember130810000000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember133689000000JPY
Net sales of goods rev oaPrior1YearDuration_NonConsolidatedMember21447000000JPY
Net sales of goods rev oaCurrentYearDuration_NonConsolidatedMember22629000000JPY
Net sales of finished goods rev oaPrior1YearDuration_NonConsolidatedMember24843000000JPY
Net sales of finished goods rev oaCurrentYearDuration_NonConsolidatedMember25933000000JPY
Other sales rev oaPrior1YearDuration_NonConsolidatedMember697000000JPY
Other sales rev oaCurrentYearDuration_NonConsolidatedMember332000000JPY
Net salesPrior1YearDuration_NonConsolidatedMember46987000000JPY
Net salesCurrentYearDuration_NonConsolidatedMember48896000000JPY
Beginning merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember4285000000JPY
Beginning merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember5542000000JPY
Cost of purchased goodsPrior1YearDuration_NonConsolidatedMember11990000000JPY
Cost of purchased goodsCurrentYearDuration_NonConsolidatedMember12204000000JPY
Cost of products manufacturedPrior1YearDuration_NonConsolidatedMember11862000000JPY
Cost of products manufacturedCurrentYearDuration_NonConsolidatedMember13870000000JPY
Total beginning and cost purchased merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember28139000000JPY
Total beginning and cost purchased merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember31617000000JPY
Transfer to other account cosPrior1YearDuration_NonConsolidatedMember4000000JPY
Transfer to other account cosCurrentYearDuration_NonConsolidatedMember14000000JPY
Ending merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember5542000000JPY
Ending merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember6165000000JPY
Net cos merchandise and finished goodsPrior1YearDuration_NonConsolidatedMember22591000000JPY
Net cos merchandise and finished goodsCurrentYearDuration_NonConsolidatedMember25437000000JPY
Other cost cos exp oaPrior1YearDuration_NonConsolidatedMember57000000JPY
Other cost cos exp oaCurrentYearDuration_NonConsolidatedMember79000000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember22649000000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember25516000000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember24338000000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember23379000000JPY
Promotion expenses sgaPrior1YearDuration_NonConsolidatedMember4187000000JPY
Promotion expenses sgaCurrentYearDuration_NonConsolidatedMember1581000000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember4475000000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember4515000000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember381000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember385000000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember182000000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember166000000JPY
Commission sgaPrior1YearDuration_NonConsolidatedMember2530000000JPY
Commission sgaCurrentYearDuration_NonConsolidatedMember2642000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember259000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember234000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember832000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember1661000000JPY
Other sgaPrior1YearDuration_NonConsolidatedMember6833000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass